ApoA-I induced CD31 in bone marrow-derived vascular progenitor cells increases adhesion

Implications for vascular repair

Karthikeyan Mythreye, Lisa L. Satterwhite, W. Sean Davidson, Pascal Goldschmidt-Clermont

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Transgenic over expression of apolipoprotein A-I (ApoA-I) the major structural apolipoprotein of HDL appears to convey the most consistent and strongest anti atherogenic effect observed in animal models so far. We tested the hypothesis that ApoA-I mediates its cardio protective effects additionally through ApoA-I induced differentiation of bone marrow-derived progenitor cells in vitro. This study demonstrates that lineage negative bone marrow cells (lin- BMCs) alter and differentiate in response to free ApoA-I. We find that lin- BMCs in culture treated with recombinant free ApoA-I at a concentration of 0.4 μM are twice as large in size and have altered cell morphology compared to untreated cells; untreated cells retain the original spheroid morphology. Further, the total number of CD31 positive cells in the ApoA-I treated population consistently increased by two fold. This phenotype was significantly reduced in untreated cells and points towards a novel ApoA-I dependent differentiation. A protein lacking its best lipid-binding region (ApoA-IΔ10) did not stimulate any changes in the lin-BMCs indicating that ApoA-I may mediate its effects by regulating cholesterol efflux. The increased CD31 correlates with an increased ability of the lin- BMCs to adhere to both fibronectin and mouse brain endothelial cells. Our results provide the first evidence that exogenous free ApoA-I has the capacity to change the characteristics of progenitor cell populations and suggests a novel mechanism by which HDL may mediate its cardiovascular benefits.

Original languageEnglish
Pages (from-to)703-709
Number of pages7
JournalBiochimica et Biophysica Acta - Molecular and Cell Biology of Lipids
Volume1781
Issue number11-12
DOIs
StatePublished - Nov 1 2008

Fingerprint

Apolipoprotein A-I
Cell Adhesion
Blood Vessels
Stem Cells
Bone Marrow
Bone Marrow Cells
Apolipoproteins A
Apolipoproteins
Fibronectins
Population
Endothelial Cells
Animal Models
Cell Culture Techniques
Cholesterol
Phenotype
Lipids
Brain

Keywords

  • Adhesion
  • ApoA-I
  • Bone marrow cells (BMCs)
  • CD31
  • Lineage minus
  • Vascular progenitor cell

ASJC Scopus subject areas

  • Cell Biology
  • Molecular Biology

Cite this

ApoA-I induced CD31 in bone marrow-derived vascular progenitor cells increases adhesion : Implications for vascular repair. / Mythreye, Karthikeyan; Satterwhite, Lisa L.; Davidson, W. Sean; Goldschmidt-Clermont, Pascal.

In: Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids, Vol. 1781, No. 11-12, 01.11.2008, p. 703-709.

Research output: Contribution to journalArticle

Mythreye, Karthikeyan ; Satterwhite, Lisa L. ; Davidson, W. Sean ; Goldschmidt-Clermont, Pascal. / ApoA-I induced CD31 in bone marrow-derived vascular progenitor cells increases adhesion : Implications for vascular repair. In: Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids. 2008 ; Vol. 1781, No. 11-12. pp. 703-709.
@article{308e380407714138947ee607f01f6b76,
title = "ApoA-I induced CD31 in bone marrow-derived vascular progenitor cells increases adhesion: Implications for vascular repair",
abstract = "Transgenic over expression of apolipoprotein A-I (ApoA-I) the major structural apolipoprotein of HDL appears to convey the most consistent and strongest anti atherogenic effect observed in animal models so far. We tested the hypothesis that ApoA-I mediates its cardio protective effects additionally through ApoA-I induced differentiation of bone marrow-derived progenitor cells in vitro. This study demonstrates that lineage negative bone marrow cells (lin- BMCs) alter and differentiate in response to free ApoA-I. We find that lin- BMCs in culture treated with recombinant free ApoA-I at a concentration of 0.4 μM are twice as large in size and have altered cell morphology compared to untreated cells; untreated cells retain the original spheroid morphology. Further, the total number of CD31 positive cells in the ApoA-I treated population consistently increased by two fold. This phenotype was significantly reduced in untreated cells and points towards a novel ApoA-I dependent differentiation. A protein lacking its best lipid-binding region (ApoA-IΔ10) did not stimulate any changes in the lin-BMCs indicating that ApoA-I may mediate its effects by regulating cholesterol efflux. The increased CD31 correlates with an increased ability of the lin- BMCs to adhere to both fibronectin and mouse brain endothelial cells. Our results provide the first evidence that exogenous free ApoA-I has the capacity to change the characteristics of progenitor cell populations and suggests a novel mechanism by which HDL may mediate its cardiovascular benefits.",
keywords = "Adhesion, ApoA-I, Bone marrow cells (BMCs), CD31, Lineage minus, Vascular progenitor cell",
author = "Karthikeyan Mythreye and Satterwhite, {Lisa L.} and Davidson, {W. Sean} and Pascal Goldschmidt-Clermont",
year = "2008",
month = "11",
day = "1",
doi = "10.1016/j.bbalip.2008.08.002",
language = "English",
volume = "1781",
pages = "703--709",
journal = "Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids",
issn = "1388-1981",
publisher = "Elsevier",
number = "11-12",

}

TY - JOUR

T1 - ApoA-I induced CD31 in bone marrow-derived vascular progenitor cells increases adhesion

T2 - Implications for vascular repair

AU - Mythreye, Karthikeyan

AU - Satterwhite, Lisa L.

AU - Davidson, W. Sean

AU - Goldschmidt-Clermont, Pascal

PY - 2008/11/1

Y1 - 2008/11/1

N2 - Transgenic over expression of apolipoprotein A-I (ApoA-I) the major structural apolipoprotein of HDL appears to convey the most consistent and strongest anti atherogenic effect observed in animal models so far. We tested the hypothesis that ApoA-I mediates its cardio protective effects additionally through ApoA-I induced differentiation of bone marrow-derived progenitor cells in vitro. This study demonstrates that lineage negative bone marrow cells (lin- BMCs) alter and differentiate in response to free ApoA-I. We find that lin- BMCs in culture treated with recombinant free ApoA-I at a concentration of 0.4 μM are twice as large in size and have altered cell morphology compared to untreated cells; untreated cells retain the original spheroid morphology. Further, the total number of CD31 positive cells in the ApoA-I treated population consistently increased by two fold. This phenotype was significantly reduced in untreated cells and points towards a novel ApoA-I dependent differentiation. A protein lacking its best lipid-binding region (ApoA-IΔ10) did not stimulate any changes in the lin-BMCs indicating that ApoA-I may mediate its effects by regulating cholesterol efflux. The increased CD31 correlates with an increased ability of the lin- BMCs to adhere to both fibronectin and mouse brain endothelial cells. Our results provide the first evidence that exogenous free ApoA-I has the capacity to change the characteristics of progenitor cell populations and suggests a novel mechanism by which HDL may mediate its cardiovascular benefits.

AB - Transgenic over expression of apolipoprotein A-I (ApoA-I) the major structural apolipoprotein of HDL appears to convey the most consistent and strongest anti atherogenic effect observed in animal models so far. We tested the hypothesis that ApoA-I mediates its cardio protective effects additionally through ApoA-I induced differentiation of bone marrow-derived progenitor cells in vitro. This study demonstrates that lineage negative bone marrow cells (lin- BMCs) alter and differentiate in response to free ApoA-I. We find that lin- BMCs in culture treated with recombinant free ApoA-I at a concentration of 0.4 μM are twice as large in size and have altered cell morphology compared to untreated cells; untreated cells retain the original spheroid morphology. Further, the total number of CD31 positive cells in the ApoA-I treated population consistently increased by two fold. This phenotype was significantly reduced in untreated cells and points towards a novel ApoA-I dependent differentiation. A protein lacking its best lipid-binding region (ApoA-IΔ10) did not stimulate any changes in the lin-BMCs indicating that ApoA-I may mediate its effects by regulating cholesterol efflux. The increased CD31 correlates with an increased ability of the lin- BMCs to adhere to both fibronectin and mouse brain endothelial cells. Our results provide the first evidence that exogenous free ApoA-I has the capacity to change the characteristics of progenitor cell populations and suggests a novel mechanism by which HDL may mediate its cardiovascular benefits.

KW - Adhesion

KW - ApoA-I

KW - Bone marrow cells (BMCs)

KW - CD31

KW - Lineage minus

KW - Vascular progenitor cell

UR - http://www.scopus.com/inward/record.url?scp=56049101134&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=56049101134&partnerID=8YFLogxK

U2 - 10.1016/j.bbalip.2008.08.002

DO - 10.1016/j.bbalip.2008.08.002

M3 - Article

VL - 1781

SP - 703

EP - 709

JO - Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

JF - Biochimica et Biophysica Acta - Molecular and Cell Biology of Lipids

SN - 1388-1981

IS - 11-12

ER -